METex14-Positive NSCLC: Time to Take the Therapy to the Target to Aim for a Cure?

J Thorac Oncol. 2017 Aug;12(8):1180-1182. doi: 10.1016/j.jtho.2017.06.009.

Authors

Viola W Zhu¹, Sai-Hong Ignatius Ou²

Affiliations

¹ Department of Medicine, Division of Hematology-Oncology, University of California Irvine School of Medicine, Orange, California; Hematology/Oncology Section, Veterans Affairs Long Beach Healthcare System, Long Beach, California.
² Department of Medicine, Division of Hematology-Oncology, University of California Irvine School of Medicine, Orange, California. Electronic address: Ignatius.ou@uci.edu.

PMID: 28748813
DOI: 10.1016/j.jtho.2017.06.009

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms*
Proto-Oncogene Proteins c-met

Substances

Proto-Oncogene Proteins c-met